Elbasvir is a medication used to treat chronic hepatitis C virus infection. Stable isotopes of elbasvir are isotopes that do not undergo radioactive decay and are used in research studies to track the metabolism and distribution of the medication in the body. These isotopes provide valuable information about the drug's efficacy and potential side effects, which can aid in the development of safer and more effective treatments for hepatitis C.